Pharmafile Logo
Pharmafocus logo
Advanced Search

tislelizumab

Showing 1 posts of 1 posts found.

screenshot_2021-01-14_file_beigene_ltd_-_panoramio_1_jpg_-_wikimedia_commons

BeiGene’s tislelizumab gets China approval for non-small cell lung cancer

January 14, 2021
BeiGene, Cancer, tislelizumab

BeiGene Ltd has announced that its anti-PD-1 antibody tislelizumab has received approval from the China National Medical Products Administration (NMPA) …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026